Skip to main content
. 2021 Aug 17;110:216–222. doi: 10.1016/j.procbio.2021.08.015

Table 2.

Inhibitors showing binding affinities against active sites of target proteins.


RdRp
Mpro
Spike glycoprotein
Sr. # Ligand PubChem ID Energy score (kcal/mol) (MOE) Molecular Operating Environment Binding Affinity (KD) Dissociation Constant (Discovery studio) Energy score (kcal/mol) (MOE) Binding Affinity (KD) (Discovery studio) Energy score (kcal/mol) (MOE) Binding Affinity (KD) (Discovery studio)
1 Teprotide 443,376 −7.25 −9.7 −10.95 −12.4 −6.95 −10.9
2 Moexipril 91,270 −10.27 −13.5 −7.55 −7.1 −5.93 −7.3
3 Cilazapril 56,330 −9.03 −9.8 −7.99 −7.9 −6.35 −7.9
4 Benazepril 5,362,124 −8.97 −8.9 −8.88 −9.0 −6.34 −7.9
5 Trandolapril 5,484,727 −6.76 −8.7 −8.04 −8.4 −6.93 −8.0
6 Quinapril 54,892 −7.74 −8.5 −8.45 −8.7 −6.32 −7.7
7 Lisinopril 5,362,119 −8.36 −8.1 −6.01 −6.7 −5.48 −6.5
8 Enalapril 5,388,962 −8.50 −8.0 −7.77 −7.7 −5.94 −7.3
9 Ramapril 121,486,657 −8.34 −8.0 −6.17 −6.9 −6.31 −7.7
10 Perindopril 107,807 N/A −6.8 −7.13 −6.9 −6.02 −7.4
11 Captopril 44,093 −5.40 −6.5 −6.00 −6.2 −5.34 −6.5
12 Allicin 65,036 No interaction −4.9 −5.90 −4.7 −5.21 −4.9